By Karen Roman Biopharmaceutical company Medera Inc. said it completed patient enrollment for Cohort B of its clinical trial ...

AB-1002 is administered via antegrade intracoronary artery infusion. The Food and Drug Administration (FDA) has granted Fast Track designation to AB-1002 for the treatment of congestive heart failure ...

Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer baseAdvance SeaStar Medical’s ...

Our top 5 heart failure articles of 2025 include FDA approvals, improving guideline-directed medical therapy (GDMT), markers of progressive heart failure (HF) such as findings from echocardiogram ...

Share on Pinterest A study finds that exercise therapy is safe and can help improve recovery and quality of life for people with heart failure. Niedring/Drentwett/Getty Images Researchers investigated ...

First-in-human trial of AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart Association (NYHA) Class III heart failure Trial enrolled 11 participants in ...

A critical review of cell-based and cell product-based therapies for the treatment of heart failure details 20 years of completed and ongoing clinical trials. While none has yet gained medical ...

Utilization of the four pillars in heart failure therapy are highlighted as aggressive first-line treatment strategies. This is a video synopsis/summary of a panel discussion involving Robert Groves, ...

Aims Sleep disordered breathing (SDB) may contribute to disease progression in patients with chronic heart failure (CHF). The objective of this observational study was to evaluate whether SDB is a ...

Atrial fibrillation (AF) and chronic heart failure (CHF) are two major and even growing cardiovascular conditions that often coexist. However, few data are available to guide treatment of AF in ...